For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fibrinolysis-treatment-validated-large-trial-acute-2026a10009im?src=rss
Author :
Publish date : 2026-03-28 21:20:00
Copyright for syndicated content belongs to the linked Source.
